Inhibition of Fas-mediated fulminant hepatitis in CrmA gene-transfected mice

Citation
Xk. Li et al., Inhibition of Fas-mediated fulminant hepatitis in CrmA gene-transfected mice, BIOC BIOP R, 273(1), 2000, pp. 101-109
Citations number
38
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
ISSN journal
0006291X → ACNP
Volume
273
Issue
1
Year of publication
2000
Pages
101 - 109
Database
ISI
SICI code
0006-291X(20000624)273:1<101:IOFFHI>2.0.ZU;2-U
Abstract
Hyperimmune response via Fas/Fas-ligand and perforin/granzyme pathways may be essential in pathogenesis of virus-induced fulminant hepatitis. CrmA inh ibits activation of caspases and granzyme B, suggesting it may block these pathways. We investigated whether CrmA expression would inhibit Fas-associa ted lethal hepatitis in mice, We successfully generated AxCALNLCrmA, a reco mbinant adenovirus expressing CrmA gene with a Cre-mediated switching casse tte. We increased CrmA expression level in the liver transfected with AxCAL NLCrmA (10(9) pfu) by increasing administration dose (10(7)-10(9) pfu) of A xCANCre, a recombinant, adenovirus-expressing Cre gene. injection of anti-F as antibody into the control mice rapidly led to animal death due to massiv e liver apoptosis, while the apoptosis was dramatically reduced in the CrmA -expressed mice. The animal survival increased with an increase of CrmA exp ression. The formation of active caspase-3 was markedly inhibited in the cr mA-transfected hepatocytes in vitro. These results suggest that crmA is an effective gene that can inhibit immune-related liver apoptosis. (C) 2000 Ac ademic Press.